Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock Life Science Investing
Arrowhead Pharmaceuticals to Participate in Upcoming December 2025 Conferences Life Science Investing
RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9th Life Science Investing
NanoViricides Has Signed a Master Services Agreement with OnlyOrphansCote Regarding Orphan Drug Strategy of NV-387 for Treatment of MPox, Smallpox, and Measles Life Science Investing
NRx Pharmaceuticals and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference Life Science Investing
Cocrystal Pharma to Present at the Noble Capital Markets' 21st Emerging Growth Equity Conference Life Science Investing
Incyte Appoints Richard Hoffman as Executive Vice President and General Counsel Life Science Investing
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions Biotech Investing
Nature Genetics Study Validates Seer's Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers Life Science Investing
Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial of BTK Degrader Bexobrutideg To Be Presented at the 67th American Society of Hematology Annual Meeting and Exposition Life Science Investing
